Faster - Reliable - Convenient
One Step Diagnostic Tests!
Influenza A
(H1N1 / Swine Flu)
A rapid Immunochromatographic test for the qualitative detection of Influenza A (H1N1 or Swine Flu) viral antigen from nasal aspirate or nasal / throat swabs samples
Click on image to enlarge |
Click for PDF file of Clinical Performance Results
Amgenix International, Inc. is pleased to introduce a Rapid Diagnostic Test for Swine Flu or H1N1 Virus: OnSight™ – Influenza A (H1N1). This is an Ideal Test for Urgent Testing situations; for instance, Doctor’s Office, Clinics, Hospital STAT Facilities and Bedside, using nasopharyngeal samples.
On June 11, 2009, the World Health Organization (WHO) raised the worldwide pandemic alert level to Phase 6 in response to the ongoing global spread of the novel influenza A (H1N1) virus. A Phase 6 designation indicates that a global pandemic is underway.
According to Centers for Disease Control and Prevention (CDC), USA more than 70 countries are now reporting cases of human infection with novel H1N1 flu. This number has been increasing over the past few weeks, but many of the cases reportedly had links to travel or were localized outbreaks without community spread. The WHO designation of a pandemic alert Phase 6 reflects the fact that there are now ongoing community level outbreaks in multiple parts of world.
WHO’s decision to raise the pandemic alert level to Phase 6 is a reflection of the spread of the virus, not the severity of illness caused by the virus.
OnSight™ – Influenza A (H1N1) test employs highly specific and sensitive monoclonal antibodies targeted at specific nucleoprotein of Influenza virus A (H1N1), thus it can quickly detect Swine or H1N1 Flu.
OnSight™ – Influenza A (H1N1) test can be widely used in clinical diagnosis, public health, Entry-Exit inspection and quarantine, especially in Airport / Coach station / rail station / School / College / Society, where has crowded people, for suspected influenza A (Swine or H1N1 Flu) cases.
OnSight™ – Influenza A (H1N1) Test can be an important diagnostic tool to reduce human exposure to emerging influenza viruses, therefore the test represents major steps toward protecting the public from the threat of pandemic flu.
For your information, I have attached Product Insert and Clinical Performance Results of OnSight™ – Influenza A (H1N1) Test to review.
Please feel free to contact us for Samples for evaluation if you decide to introduce this unique and useful product in your market. Looking forward to hearing from you soon.
Please note that we also have the following Rapid Influenza Tests:
OnSight™ – Influenza B Test (Cat No.: 551-25-DN-B)
OnSight™ – Influenza A+B Combo Test (Cat No.: 551-25-DN-AB)
Please note that OnsightTM-Influenza A (H1N1) Test is Rapid Front-line Screening test; therefore, all positive results should be confirmed by more sophisticated test methods.
Lab – Stix rapid test may be your answer !!
